Clinical Trial Update: Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating golimumab for induction and maintenance of clinical and endoscopic remission in steroid-dependent ulcerative colitis; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Colitis, Ulcerative | Phase 4 | Status: UNKNOWN